APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic and Analgesic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antipyretic and Analgesic Drugs Market Outlook and Growth Opportunities 2026

22 December 2025208 pages

Choose your research edition.

Industry ResearchAntipyretic and Analgesic Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic and Analgesic Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Antipyretic and Analgesic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic and Analgesic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic and Analgesic Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Antipyretic and Analgesic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antipyretic and Analgesic Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antipyretic and Analgesic Drugs market include Yuanhe Pharmaceutical, Xinhui Pharmaceutical, Topfond Pharmaceutical, Taile Pharmaceutical, Sanofi, Pfizer, Kys Pharm, China Resources Double-Crane Pharmaceutical and Huaan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antipyretic and Analgesic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antipyretic and Analgesic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antipyretic and Analgesic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antipyretic and Analgesic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Antipyretic and Analgesic Drugs Segment by Company

Yuanhe Pharmaceutical

Xinhui Pharmaceutical

Topfond Pharmaceutical

Taile Pharmaceutical

Sanofi

Pfizer

Kys Pharm

China Resources Double-Crane Pharmaceutical

Huaan Pharmaceutical

Hongxing Pharmaceutical

Heping Pharmaceutical

China National Medicines Guorui Pharmaceutical

Dingchang Pharmaceutical

Baotai Pharmaceutical

Bayer

SKPL

Mallinckrodt

Antipyretic and Analgesic Drugs Segment by Type

Paracetamol

Naproxen

Ibuprofen

Analgin

Aspirin

Others

Antipyretic and Analgesic Drugs Segment by Application

Hospital

Clinic

Antipyretic and Analgesic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antipyretic and Analgesic Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antipyretic and Analgesic Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antipyretic and Analgesic Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Antipyretic and Analgesic Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic and Analgesic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic and Analgesic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic and Analgesic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antipyretic and Analgesic Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antipyretic and Analgesic Drugs industry.

Chapter 3: Detailed analysis of Antipyretic and Analgesic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antipyretic and Analgesic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antipyretic and Analgesic Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antipyretic and Analgesic Drugs Industry Trends Table 2. Antipyretic and Analgesic Drugs Industry Drivers Table 3. Antipyretic and Analgesic Drugs Industry Opportunities and Challenges Table 4. Antipyretic and Analgesic Drugs Industry Restraints Table 5. Global Antipyretic and Analgesic Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antipyretic and Analgesic Drugs Revenue Share by Company (2021-2026) Table 7. Global Antipyretic and Analgesic Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Antipyretic and Analgesic Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Antipyretic and Analgesic Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Antipyretic and Analgesic Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antipyretic and Analgesic Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Antipyretic and Analgesic Drugs Company, Product Type & Application Table 13. Global Antipyretic and Analgesic Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antipyretic and Analgesic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Paracetamol Table 18. Significant Companies of Naproxen Table 19. Significant Companies of Ibuprofen Table 20. Significant Companies of Analgin Table 21. Significant Companies of Aspirin Table 22. Significant Companies of Others Table 23. Global Antipyretic and Analgesic Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Antipyretic and Analgesic Drugs Sales Volume by Type (2021-2026) & (k units) Table 25. Global Antipyretic and Analgesic Drugs Sales Volume by Type (2027-2032) & (k units) Table 26. Global Antipyretic and Analgesic Drugs Sales Volume Share by Type (2021-2026) Table 27. Global Antipyretic and Analgesic Drugs Sales Volume Share by Type (2027-2032) Table 28. Global Antipyretic and Analgesic Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Antipyretic and Analgesic Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Antipyretic and Analgesic Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Antipyretic and Analgesic Drugs Sales Value Share by Type (2021-2026) Table 32. Global Antipyretic and Analgesic Drugs Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hospital Table 34. Significant Companies of Clinic Table 35. Global Antipyretic and Analgesic Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Antipyretic and Analgesic Drugs Sales Volume by Application (2021-2026) & (k units) Table 37. Global Antipyretic and Analgesic Drugs Sales Volume by Application (2027-2032) & (k units) Table 38. Global Antipyretic and Analgesic Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Antipyretic and Analgesic Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Antipyretic and Analgesic Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Antipyretic and Analgesic Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Antipyretic and Analgesic Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Antipyretic and Analgesic Drugs Sales Value Share by Application (2021-2026) Table 44. Global Antipyretic and Analgesic Drugs Sales Value Share by Application (2027-2032) Table 45. Global Antipyretic and Analgesic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Antipyretic and Analgesic Drugs Sales by Region (2021-2026) & (k units) Table 47. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021-2026) Table 48. Global Antipyretic and Analgesic Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2027-2032) Table 50. Global Antipyretic and Analgesic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Antipyretic and Analgesic Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Antipyretic and Analgesic Drugs Sales Value Share by Region (2021-2026) Table 53. Global Antipyretic and Analgesic Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Antipyretic and Analgesic Drugs Sales Value Share by Region (2027-2032) Table 55. Global Antipyretic and Analgesic Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Antipyretic and Analgesic Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Antipyretic and Analgesic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Antipyretic and Analgesic Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 60. Global Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2026) Table 61. Global Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 62. Global Antipyretic and Analgesic Drugs Sales Market Share by Country (2027-2032) Table 63. Global Antipyretic and Analgesic Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Antipyretic and Analgesic Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Antipyretic and Analgesic Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Antipyretic and Analgesic Drugs Sales Value Market Share by Country (2027-2032) Table 67. Yuanhe Pharmaceutical Company Information Table 68. Yuanhe Pharmaceutical Business Overview Table 69. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 71. Yuanhe Pharmaceutical Recent Development Table 72. Xinhui Pharmaceutical Company Information Table 73. Xinhui Pharmaceutical Business Overview Table 74. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 76. Xinhui Pharmaceutical Recent Development Table 77. Topfond Pharmaceutical Company Information Table 78. Topfond Pharmaceutical Business Overview Table 79. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 81. Topfond Pharmaceutical Recent Development Table 82. Taile Pharmaceutical Company Information Table 83. Taile Pharmaceutical Business Overview Table 84. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 86. Taile Pharmaceutical Recent Development Table 87. Sanofi Company Information Table 88. Sanofi Business Overview Table 89. Sanofi Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Sanofi Antipyretic and Analgesic Drugs Product Portfolio Table 91. Sanofi Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Pfizer Antipyretic and Analgesic Drugs Product Portfolio Table 96. Pfizer Recent Development Table 97. Kys Pharm Company Information Table 98. Kys Pharm Business Overview Table 99. Kys Pharm Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio Table 101. Kys Pharm Recent Development Table 102. China Resources Double-Crane Pharmaceutical Company Information Table 103. China Resources Double-Crane Pharmaceutical Business Overview Table 104. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 106. China Resources Double-Crane Pharmaceutical Recent Development Table 107. Huaan Pharmaceutical Company Information Table 108. Huaan Pharmaceutical Business Overview Table 109. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 111. Huaan Pharmaceutical Recent Development Table 112. Hongxing Pharmaceutical Company Information Table 113. Hongxing Pharmaceutical Business Overview Table 114. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 116. Hongxing Pharmaceutical Recent Development Table 117. Heping Pharmaceutical Company Information Table 118. Heping Pharmaceutical Business Overview Table 119. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 121. Heping Pharmaceutical Recent Development Table 122. China National Medicines Guorui Pharmaceutical Company Information Table 123. China National Medicines Guorui Pharmaceutical Business Overview Table 124. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 126. China National Medicines Guorui Pharmaceutical Recent Development Table 127. Dingchang Pharmaceutical Company Information Table 128. Dingchang Pharmaceutical Business Overview Table 129. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 131. Dingchang Pharmaceutical Recent Development Table 132. Baotai Pharmaceutical Company Information Table 133. Baotai Pharmaceutical Business Overview Table 134. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 136. Baotai Pharmaceutical Recent Development Table 137. Bayer Company Information Table 138. Bayer Business Overview Table 139. Bayer Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Bayer Antipyretic and Analgesic Drugs Product Portfolio Table 141. Bayer Recent Development Table 142. SKPL Company Information Table 143. SKPL Business Overview Table 144. SKPL Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. SKPL Antipyretic and Analgesic Drugs Product Portfolio Table 146. SKPL Recent Development Table 147. Mallinckrodt Company Information Table 148. Mallinckrodt Business Overview Table 149. Mallinckrodt Antipyretic and Analgesic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio Table 151. Mallinckrodt Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Antipyretic and Analgesic Drugs Distributors List Table 155. Antipyretic and Analgesic Drugs Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Antipyretic and Analgesic Drugs Product Image Figure 2. Global Antipyretic and Analgesic Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antipyretic and Analgesic Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antipyretic and Analgesic Drugs Sales (2021-2032) & (k units) Figure 5. Global Antipyretic and Analgesic Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Antipyretic and Analgesic Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Paracetamol Image Figure 10. Naproxen Image Figure 11. Ibuprofen Image Figure 12. Analgin Image Figure 13. Aspirin Image Figure 14. Others Image Figure 15. Global Antipyretic and Analgesic Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Antipyretic and Analgesic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Antipyretic and Analgesic Drugs Sales Volume Share by Type (2021-2032) Figure 18. Global Antipyretic and Analgesic Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Antipyretic and Analgesic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Antipyretic and Analgesic Drugs Sales Value Share by Type (2021-2032) Figure 21. Hospital Image Figure 22. Clinic Image Figure 23. Global Antipyretic and Analgesic Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Antipyretic and Analgesic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Antipyretic and Analgesic Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Antipyretic and Analgesic Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antipyretic and Analgesic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Antipyretic and Analgesic Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Antipyretic and Analgesic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Antipyretic and Analgesic Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Antipyretic and Analgesic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Antipyretic and Analgesic Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Antipyretic and Analgesic Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Antipyretic and Analgesic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Antipyretic and Analgesic Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Antipyretic and Analgesic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Antipyretic and Analgesic Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Antipyretic and Analgesic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Antipyretic and Analgesic Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Antipyretic and Analgesic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Antipyretic and Analgesic Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Antipyretic and Analgesic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Antipyretic and Analgesic Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Antipyretic and Analgesic Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Paracetamol
  • Naproxen
  • Ibuprofen
  • Analgin
  • Aspirin
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuanhe Pharmaceutical
  • Xinhui Pharmaceutical
  • Topfond Pharmaceutical
  • Taile Pharmaceutical
  • Sanofi
  • Pfizer
  • Kys Pharm
  • China Resources Double-Crane Pharmaceutical
  • Huaan Pharmaceutical
  • Hongxing Pharmaceutical
  • Heping Pharmaceutical
  • China National Medicines Guorui Pharmaceutical
  • Dingchang Pharmaceutical
  • Baotai Pharmaceutical
  • Bayer
  • SKPL
  • Mallinckrodt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antipyretic and Analgesic Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Antipyretic and Analgesic Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Antipyretic and Analgesic Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antipyretic and Analgesic Drugs Market Dynamics
  1. 2.1 Antipyretic and Analgesic Drugs Industry Trends
  2. 2.2 Antipyretic and Analgesic Drugs Industry Drivers
  3. 2.3 Antipyretic and Analgesic Drugs Industry Opportunities and Challenges
  4. 2.4 Antipyretic and Analgesic Drugs Industry Restraints
3 Antipyretic and Analgesic Drugs Market by Company
  1. 3.1 Global Antipyretic and Analgesic Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Antipyretic and Analgesic Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Antipyretic and Analgesic Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Antipyretic and Analgesic Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Antipyretic and Analgesic Drugs Company Ranking (2024-2026)
  6. 3.6 Global Antipyretic and Analgesic Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Antipyretic and Analgesic Drugs Company Product Type and Application
  8. 3.8 Global Antipyretic and Analgesic Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antipyretic and Analgesic Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antipyretic and Analgesic Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antipyretic and Analgesic Drugs Market by Type
  1. 4.1 Antipyretic and Analgesic Drugs Type Introduction
  2. 4.1.1 Paracetamol
  3. 4.1.2 Naproxen
  4. 4.1.3 Ibuprofen
  5. 4.1.4 Analgin
  6. 4.1.5 Aspirin
  7. 4.1.6 Others
  8. 4.2 Global Antipyretic and Analgesic Drugs Sales Volume by Type
  9. 4.2.1 Global Antipyretic and Analgesic Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Antipyretic and Analgesic Drugs Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Antipyretic and Analgesic Drugs Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Antipyretic and Analgesic Drugs Sales Value by Type
  13. 4.3.1 Global Antipyretic and Analgesic Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Antipyretic and Analgesic Drugs Sales Value by Type (2021-2032)
  15. 4.3.3 Global Antipyretic and Analgesic Drugs Sales Value Share by Type (2021-2032)
5 Antipyretic and Analgesic Drugs Market by Application
  1. 5.1 Antipyretic and Analgesic Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Antipyretic and Analgesic Drugs Sales Volume by Application
  5. 5.2.1 Global Antipyretic and Analgesic Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antipyretic and Analgesic Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Antipyretic and Analgesic Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Antipyretic and Analgesic Drugs Sales Value by Application
  9. 5.3.1 Global Antipyretic and Analgesic Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antipyretic and Analgesic Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Antipyretic and Analgesic Drugs Sales Value Share by Application (2021-2032)
6 Antipyretic and Analgesic Drugs Regional Sales and Value Analysis
  1. 6.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antipyretic and Analgesic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Antipyretic and Analgesic Drugs Sales by Region (2027-2032)
  5. 6.3 Global Antipyretic and Analgesic Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antipyretic and Analgesic Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antipyretic and Analgesic Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antipyretic and Analgesic Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Antipyretic and Analgesic Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antipyretic and Analgesic Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Antipyretic and Analgesic Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antipyretic and Analgesic Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Antipyretic and Analgesic Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antipyretic and Analgesic Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antipyretic and Analgesic Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antipyretic and Analgesic Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Antipyretic and Analgesic Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antipyretic and Analgesic Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antipyretic and Analgesic Drugs Sales Value Share by Country, 2025 VS 2032
7 Antipyretic and Analgesic Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Antipyretic and Analgesic Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antipyretic and Analgesic Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Antipyretic and Analgesic Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Antipyretic and Analgesic Drugs Sales by Country (2027-2032)
  6. 7.4 Global Antipyretic and Analgesic Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antipyretic and Analgesic Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antipyretic and Analgesic Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antipyretic and Analgesic Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antipyretic and Analgesic Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antipyretic and Analgesic Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuanhe Pharmaceutical
  2. 8.1.1 Yuanhe Pharmaceutical Company Information
  3. 8.1.2 Yuanhe Pharmaceutical Business Overview
  4. 8.1.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  6. 8.1.5 Yuanhe Pharmaceutical Recent Developments
  7. 8.2 Xinhui Pharmaceutical
  8. 8.2.1 Xinhui Pharmaceutical Company Information
  9. 8.2.2 Xinhui Pharmaceutical Business Overview
  10. 8.2.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  12. 8.2.5 Xinhui Pharmaceutical Recent Developments
  13. 8.3 Topfond Pharmaceutical
  14. 8.3.1 Topfond Pharmaceutical Company Information
  15. 8.3.2 Topfond Pharmaceutical Business Overview
  16. 8.3.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  18. 8.3.5 Topfond Pharmaceutical Recent Developments
  19. 8.4 Taile Pharmaceutical
  20. 8.4.1 Taile Pharmaceutical Company Information
  21. 8.4.2 Taile Pharmaceutical Business Overview
  22. 8.4.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  24. 8.4.5 Taile Pharmaceutical Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Antipyretic and Analgesic Drugs Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Antipyretic and Analgesic Drugs Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Kys Pharm
  38. 8.7.1 Kys Pharm Company Information
  39. 8.7.2 Kys Pharm Business Overview
  40. 8.7.3 Kys Pharm Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio
  42. 8.7.5 Kys Pharm Recent Developments
  43. 8.8 China Resources Double-Crane Pharmaceutical
  44. 8.8.1 China Resources Double-Crane Pharmaceutical Company Information
  45. 8.8.2 China Resources Double-Crane Pharmaceutical Business Overview
  46. 8.8.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  48. 8.8.5 China Resources Double-Crane Pharmaceutical Recent Developments
  49. 8.9 Huaan Pharmaceutical
  50. 8.9.1 Huaan Pharmaceutical Company Information
  51. 8.9.2 Huaan Pharmaceutical Business Overview
  52. 8.9.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  54. 8.9.5 Huaan Pharmaceutical Recent Developments
  55. 8.10 Hongxing Pharmaceutical
  56. 8.10.1 Hongxing Pharmaceutical Company Information
  57. 8.10.2 Hongxing Pharmaceutical Business Overview
  58. 8.10.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  60. 8.10.5 Hongxing Pharmaceutical Recent Developments
  61. 8.11 Heping Pharmaceutical
  62. 8.11.1 Heping Pharmaceutical Company Information
  63. 8.11.2 Heping Pharmaceutical Business Overview
  64. 8.11.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  66. 8.11.5 Heping Pharmaceutical Recent Developments
  67. 8.12 China National Medicines Guorui Pharmaceutical
  68. 8.12.1 China National Medicines Guorui Pharmaceutical Company Information
  69. 8.12.2 China National Medicines Guorui Pharmaceutical Business Overview
  70. 8.12.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  72. 8.12.5 China National Medicines Guorui Pharmaceutical Recent Developments
  73. 8.13 Dingchang Pharmaceutical
  74. 8.13.1 Dingchang Pharmaceutical Company Information
  75. 8.13.2 Dingchang Pharmaceutical Business Overview
  76. 8.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  78. 8.13.5 Dingchang Pharmaceutical Recent Developments
  79. 8.14 Baotai Pharmaceutical
  80. 8.14.1 Baotai Pharmaceutical Company Information
  81. 8.14.2 Baotai Pharmaceutical Business Overview
  82. 8.14.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  84. 8.14.5 Baotai Pharmaceutical Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Antipyretic and Analgesic Drugs Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 SKPL
  92. 8.16.1 SKPL Company Information
  93. 8.16.2 SKPL Business Overview
  94. 8.16.3 SKPL Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 SKPL Antipyretic and Analgesic Drugs Product Portfolio
  96. 8.16.5 SKPL Recent Developments
  97. 8.17 Mallinckrodt
  98. 8.17.1 Mallinckrodt Company Information
  99. 8.17.2 Mallinckrodt Business Overview
  100. 8.17.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio
  102. 8.17.5 Mallinckrodt Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antipyretic and Analgesic Drugs Value Chain Analysis
  2. 9.1.1 Antipyretic and Analgesic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antipyretic and Analgesic Drugs Sales Mode & Process
  6. 9.2 Antipyretic and Analgesic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antipyretic and Analgesic Drugs Distributors
  9. 9.2.3 Antipyretic and Analgesic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst